ÂÜÀòÂÒÂ×

Aaron Cameron has worked in a variety of roles in the pharmaceutical industry since 2006. Aaron began their career at MSD as a Process Chemist and Process Leader, working on the development, technology transfer, commercialization and continuous improvement of bulk tablet and sterile vial manufacturing processes. In 2012, they moved to MSD Swords as an Operations Coach, Hormonal Tablets and Creams, leading manufacturing operations in the Bulk Tabletting Division of the Hormonal Tablets and Creams Business Unit. In 2013, they joined Mylan Global Respiratory Group as Director, Technology Transfer and Process Development (Drug and Device) and Senior Manager, Drug Product Operations. In 2016, they moved to Iterum Therapeutics plc as VP, Global Supply Chain & Logistics and Director, Drug Product Development and Manufacturing. Most recently, in 2020, they joined Mylan as Head of Device Program Management, leading Mylan's Medical Device and Combination Product Program Management organisation and PMO. In 2021, they joined GH Research as VP, Technical Development and VP, Technical Development, seeking ultra-rapid, durable remissions in Depression.

Aaron Cameron completed a Master of Business Administration (MBA) (Distinction) from the University of Bradford between 2018 and 2020. Prior to that, they obtained an MSc in Industrial Pharmaceutical Science from the Royal College of Surgeons in Ireland between 2010 and 2011. Their undergraduate studies were completed at Dublin City University, where they earned a BSc in Chemical and Pharmaceutical Science between 2002 and 2006.